Cipla’s ‘inhaled insulin’ from US’ MannKind Corp adds a ‘layer of convenience’ for those with diabetes
Cipla to introduce Afrezza, an inhaled insulin for diabetes, offering convenience but not advised for lung-related concerns.
PharmiWeb7h
Global Insulin Delivery Devices Market Poised for Significant Growth, Projected to Reach USD 40.8 Billion by 2032
A Cornerstone in Diabetes ManagementInsulin delivery devices market are innovative medical instruments designed to provide ...
Noom Offers Oral Medications For Weight Loss Starting at $29
A $29 entry price helps provide accessibility for people pursuing weight loss goalsService includes all features of Noom Med ...
Saudi Arabia Glucometers Market, Competition, Forecast and Opportunities to 2029
Saudi Arabia's Glucometer Market Expected to Soar Amidst Technological Advances and Heightened Diabetes Awareness Saudi ...
The New York Times20h
New York Times - Top Stories
Christopher Wray Will Step Down as F.B.I. Director President-elect Trump had already signaled his intention to replace Mr. Wray with a longtime loyalist, Kash Patel. U.S. Colleges Warn Foreign ...
NPR16h
Business
December 12, 2024 • In 2012, Karam Shaar had to leave his home country of Syria due to the civil war. But he still wanted to make a difference. Through his economic analysis, he uncovered ...
Rugbypass1h
Rugby News
New Zealand Rugby have revealed the nation’s Under 18s squads for the Global Youth Sevens in Auckland this weekend. Seven Wallabies have been ranked among the sport’s elite in the RugbyPass Top 100 ...
cryptonews9h
Latest Crypto News
US Bankers Are Cautious Towards Cryptos Despite Upcoming Pro-Crypto Administration ...